Ladenburg Thalmann Assumes Compass Therapeutics (CMPX) at Buy

July 1, 2026 6:35 AM

Ladenburg Thalmann analyst Kevin DeGeeter assumes coverage on Compass Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found